Physician profile
Michael Travis Nilmeier
NPI 1588023220
$410.30
in general payments reported to CMS, 2019-2025
11 companies · $173 in 2025
The $173 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $17.12 · 2021: $70.00 · 2022: $32.38 · 2023: $118 · 2025: $173.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $291.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $290.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $92.56 | 2022-2023 | Quviviq |
| Merck Sharp & Dohme LLC | $61.02 | 2025 | Capvaxive, M-M-R II, Gardasil 9 |
| Abbvie INC. | $44.56 | 2021-2023 | |
| Alkermes, INC. | $37.79 | 2022-2023 | Vivitrol |
| Indivior INC. | $34.03 | 2025 | Sublocade |
| Allergan, INC. | $31.65 | 2020-2021 | |
| Edwards Lifesciences Corporation | $27.75 | 2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Pfizer INC. | $26.58 | 2025 | |
| Hologic Sales and Service, LLC | $23.52 | 2025 | Thinprep 2000 Processor |
| Genentech USA, INC. | $15.49 | 2021 | |
| Medline Industries LP | $15.35 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Nilmeier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.